共 22 条
Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with Positive Blood Cultures
被引:0
作者:
Beganovic, Maya
[1
,3
]
Costello, Michael
[2
]
Wieczorkiewicz, Sarah M.
[1
]
机构:
[1] Advocate Lutheran Gen Hosp, Dept Pharm, Park Ridge, IL 60068 USA
[2] ACL Labs, Milwaukee, WI USA
[3] Providence Vet Affairs Med Ctr, Isl Infect Dis Res Program, Providence, RI 02908 USA
关键词:
MALDI-TOF MS;
antimicrobial stewardship;
rapid molecular diagnostics;
RAPID MICROARRAY ASSAY;
STREAM INFECTIONS;
IMPACT;
OUTCOMES;
IDENTIFICATION;
TECHNOLOGY;
BACTEREMIA;
CARE;
D O I:
10.1128/JCM.02245-16
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) decreases the time to organism identification and improves clinical and financial outcomes. The purpose of this study was to evaluate the impact of MALDI-TOF MS alone versus MALDI-TOF MS combined with real-time, pharmacist-driven, antimicrobial stewardship (AMS) intervention on patient outcomes. This single-center, pre-post, quasiexperimental study evaluated hospitalized patients with positive blood cultures identified via MALDI-TOF MS combined with prospective AMS intervention compared to a control cohort with MALDI-TOF MS identification without AMS intervention. AMS intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provider feedback. The primary outcome was the time to optimal therapy (TTOT). A total of 252 blood cultures, 126 in each group, were included in the final analysis. MALDI-TOF MS plus AMS intervention significantly reduced the overall TTOT (75.17 versus 43.06 h; P < 0.001), the Gram-positive contaminant TTOT (48.21 versus 11.75 h; P < 0.001), the Gram-negative infection (GNI) TTOT (71.83 versus 35.98 h; P < 0.001), and the overall hospital length of stay (LOS; 15.03 versus 9.02 days; P = 0.021). The TTOT for Gram-positive infection (GPI) was improved (64.04 versus 41.61 h; P = 0.082). For GPI, the hospital LOS (14.64 versus 10.31 days; P = 0.002) and length of antimicrobial therapy 24.30 versus 18.97 days; P = 0.018) were reduced. For GNI, the time to microbiologic clearance (51.13 versus 34.51 h; P < 0.001), the hospital LOS (15.40 versus 7.90 days; P = 0.027), and the intensive care unit LOS (5.55 versus 1.19 days; P = 0.035) were reduced. To achieve optimal outcomes, rapid identification with MALDI-TOF MS combined with real-time AMS intervention is more impactful than MALDI-TOF MS alone.
引用
收藏
页码:1437 / 1445
页数:9
相关论文